Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France

INTRODUCTION: Because patients and patient organizations want to strengthen their role in the care pathway and drug evaluation and in order to improve pharmacovigilance activities, European competent authorities implemented regulations to allow direct reporting of adverse drug reactions related to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Adopo, D., Daynes, P., Benkebil, M., Debs, A., Jonville-Berra, AP., Polard, E., Micallef, J., Maison, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744045/
https://www.ncbi.nlm.nih.gov/pubmed/36508012
http://dx.doi.org/10.1007/s00228-022-03422-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744045/
https://www.ncbi.nlm.nih.gov/pubmed/36508012
http://dx.doi.org/10.1007/s00228-022-03422-y

Ejemplares similares